Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
M.D. Anderson Cancer Center
Day One Biopharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Aprea Therapeutics
Black Diamond Therapeutics, Inc.
Elevation Oncology
Stanford University
AstraZeneca
Merck Sharp & Dohme LLC
VA Office of Research and Development
Eli Lilly and Company
Pfizer
ADC Therapeutics S.A.
Pfizer
Pfizer
Rutgers, The State University of New Jersey
pharmaand GmbH
Genmab
Revolution Medicines, Inc.
Ludwig Institute for Cancer Research
Pfizer
Incyte Corporation
EMD Serono
Seagen Inc.
Gilead Sciences
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Bayer
Seagen Inc.
ADC Therapeutics S.A.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dartmouth-Hitchcock Medical Center
Butler Hospital
University of Kansas Medical Center
Beth Israel Deaconess Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
Amgen
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Sandoz
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc